Multi-dimensional co-separation analysis reveals protein-protein interactions defining plasma lipoprotein subspecies

Molecular and Cellular Proteomics

Volumn 12, Issue 11, 2013, Pages 3123-3134

  Gordon, Scott M ^a   Deng, Jingyuan ^b   Tomann, Alex B ^a   Shah, Amy S ^c   Lu, L Jason ^b   Davidson, W Sean ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; PHOSPHOLIPID;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; GEL FILTRATION CHROMATOGRAPHY; HUMAN; ISOELECTRIC FOCUSING; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SUBSPECIES;

ADULT; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; HUMANS; ISOELECTRIC FOCUSING; LIPOPROTEINS; LIPOPROTEINS, HDL; MALE; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84884148830     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.028134     Document Type: Article

References (43)

1. Grundy, S. M., Cleeman, J. I., Merz, C. N., Brewer, H. B. Jr., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C. Jr., and Stone, N. J. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler. Thromb. Vasc. Biol. 24, e149-e161.
2. Mackness, B., and Mackness, M. (2012) The antioxidant properties of high-density lipoproteins in atherosclerosis. Panminerva Med. 54, 83-90.
3. Bandeali, S., and Farmer, J. (2012) High-density lipoprotein and atherosclerosis: The role of antioxidant activity. Curr. Atheroscler. Rep. 14, 101-107.
4. Kontush, A., and Chapman, M. J. (2012) High-density Lipoproteins: Structure, Metabolism, Function and Therapeutics, Wiley & Sons, New York.
5. Boden, W. E., Probstfield, J. L., Anderson, T., Chaitman, B. R., Desvignes- Nickens, P., Koprowicz, K., McBride, R., Teo, K., and Weintraub, W. (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365, 2255-2267.
6. Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J. C., Waters, D. D., Shear, C. L., Revkin, J. H., Buhr, K. A., Fisher, M. R., Tall, A. R., and Brewer, B. (2007) Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109-2122. (Pubitemid 350146106)
7. Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J., Mundl, H., Nicholls, S. J., Shah, P. K., Tardif, J. C., and Wright, R. S. (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367, 2089-2099.
8. Austin, M. A., King, M. C., Vranizan, K. M., Newman, B., and Krauss, R. M. (1988) Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. Am. J. Hum. Genet. 43, 838-846. (Pubitemid 19018985)
9. Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. C., and Krauss, R. M. (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260, 1917-1921.
10. Kontush, A., Chantepie, S., and Chapman, M. J. (2003) Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler. Thromb. Vasc. Biol. 23, 1881-1888. (Pubitemid 37254879)
11. Gordon, S. M., Deng, J., Lu, L. J., and Davidson, W. S. (2010) Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Res. 9, 5239-5249.
12. Asztalos, B. F., Sloop, C. H., Wong, L., and Roheim, P. S. (1993) Twodimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim. Biophys. Acta 1169, 291-300. (Pubitemid 23264886)
13. Cheung, M. C., Segrest, J. P., Albers, J. J., Cone, J. T., Brouillette, C. G., Chung, B. H., Kashyap, M., Glasscock, M. A., and Anantharamaiah, G. M. (1987) Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J. Lipid Res. 28, 913-929. (Pubitemid 17143372)
14. Heinecke, J. W. (2009) The HDL proteome: A marker-and perhaps mediator- of coronary artery disease. J. Lipid Res. 50 Suppl, S167-S171.
15. Shah, A. S., Tan, L., Lu, L. J., and Davidson, W. S. (2013) The proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J. Lipid Res. 54, 2575-2585.
16. Hoofnagle, A. N., and Heinecke, J. W. (2009) Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins. J. Lipid Res. 50, 1967-1975.
17. Shiflett, A. M., Bishop, J. R., Pahwa, A., and Hajduk, S. L. (2005) Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes. J. Biol. Chem. 280, 32578-32585. (Pubitemid 41368299)
18. Asztalos, B. F., and Schaefer, E. J. (2003) High-density lipoprotein subpopulations in pathologic conditions. Am. J. Cardiol. 91, 12E-17E. (Pubitemid 36385070)
19. Davidson, W. S., Silva, R. A., Chantepie, S., Lagor, W. R., Chapman, M. J., and Kontush, A. (2009) Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870-876.
20. Gordon, S., Durairaj, A., Lu, J., and Davidson, W. S. (2010) High-density lipoprotein proteomics: identifying new drug targets and biomarkers by understanding functionality. Curr. Cardiovasc. Risk Rep. 4, 1-8.
21. Li, Y. (2011) The tandem affinity purification technology: An overview. Biotechnol. Lett. 33, 1487-1499.
22. Dong, M., Yang, L. L., Williams, K., Fisher, S. J., Hall, S. C., Biggin, M. D., Jin, J., and Witkowska, H. E. (2008) A "tagless" strategy for identification of stable protein complexes genome-wide by multidimensional orthogonal chromatographic separation and iTRAQ reagent tracking. J. Pro-teome Res. 7, 1836-1849.
23. Hirowatari, Y., Yoshida, H., Kurosawa, H., Doumitu, K. I., and Tada, N. (2003) Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J. Lipid Res. 44, 1404-1412. (Pubitemid 37279623)
24. Markwell, M. A., Haas, S. M., Bieber, L. L., and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87, 206-210. (Pubitemid 9050428)
25. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392. (Pubitemid 35215372)
26. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658. (Pubitemid 37082259)
27. Lacroix, R., and Dignat-George, F. (2012) Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb. Res. 129 Suppl 2, S27-S29.
28. Kunitake, S. T., La Sala, K. J., and Kane, J. P. (1985) Apolipoprotein A-I-containing lipoproteins with pre-beta electrophoretic mobility. J. Lipid Res. 26, 549-555. (Pubitemid 15073726)
29. Noble, R. P. (1968) Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 9, 693-700.
30. Andersen, J. S., Wilkinson, C. J., Mayor, T., Mortensen, P., Nigg, E. A., and Mann, M. (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426, 570-574. (Pubitemid 37522644)
31. Stahlman, M., Davidsson, P., Kanmert, I., Rosengren, B., Boren, J., Fagerberg, B., and Camejo, G. (2008) Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr. J. Lipid Res. 49, 481-490. (Pubitemid 351213633)
32. Kunitake, S. T., and Kane, J. P. (1982) Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J. Lipid Res. 23, 936-940. (Pubitemid 13244367)
33. McKee, P. A., Mattock, P., and Hill, R. L. (1970) Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc. Natl. Acad. Sci. U.S.A. 66, 738-744.
34. Capra, J. D., and Hopper, J. E. (1976) Comparative studies on monotypic IgM lambda and IgG kappa from an individual patient-III. The complete amino acid sequence of the VH region of the IgM paraprotein. Immunochemistry 13, 995-999. (Pubitemid 8009821)
35. Malki, N., Balduyck, M., Maes, P., Capon, C., Mizon, C., Han, K. K., Tartar, A., Fournet, B., and Mizon, J. (1992) The heavy chains of human plasma inter-alpha-trypsin inhibitor: Their isolation, their identification by electrophoresis and partial sequencing. Differential reactivity with concanavalin A. Biol. Chem. Hoppe Seyler 373, 1009-1018.
36. Steckel, E. W., York, R. G., Monahan, J. B., and Sodetz, J. M. (1980) The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure. J. Biol. Chem. 255, 11997-12005. (Pubitemid 11128428)
37. Cheung, M. C., and Albers, J. J. (1984) Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259, 12201-12209. (Pubitemid 14019758)
38. Raper, J., Fung, R., Ghiso, J., Nussenzweig, V., and Tomlinson, S. (1999) Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910-1916. (Pubitemid 29144414)
39. Jaeger, B. R., Marx, P., Pfefferkorn, T., Hamann, G., and Seidel, D. (1999) Heparin-mediated extracorporeal LDL/fibrinogen precipitation-H.E.L.P.- in coronary and cerebral ischemia. Acta Neurochir. Suppl. 73, 81-84.
40. Schroeder, H., Skelly, P. J., Zipfel, P. F., Losson, B., and Vanderplasschen, A. (2009) Subversion of complement by hematophagous parasites. Dev. Comp. Immunol. 33, 5-13.
41. Schwartz, G. G., Olsson, A. G., Ballantyne, C. M., Barter, P. J., Holme, I. M., Kallend, D., Leiter, L. A., Leitersdorf, E., McMurray, J. J., Shah, P. K., Tardif, J. C., Chaitman, B. R., Duttlinger-Maddux, R., and Mathieson, J. (2009) Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am. Heart J. 158, 896-901.
42. Vaisar, T. (2012) Proteomics investigations of HDL: challenges and promise. Curr. Vasc. Pharmacol. 10, 410-421.
43. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., and Ideker, T. (2003) Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504. (Pubitemid 37428274)